Skip to main content

Peer Review reports

From: Empagliflozin in kidney transplant recipients with chronic kidney disease G3a-4 and metabolic syndrome: Five Japanese cases

Original Submission
15 Aug 2021 Submitted Original manuscript
14 Sep 2021 Author responded Author comments - RYOICHI MIYAZAKI
Resubmission - Version 2
14 Sep 2021 Submitted Manuscript version 2
21 Sep 2021 Author responded Author comments - RYOICHI MIYAZAKI
Resubmission - Version 3
21 Sep 2021 Submitted Manuscript version 3
18 Nov 2021 Author responded Author comments - RYOICHI MIYAZAKI
Resubmission - Version 4
18 Nov 2021 Submitted Manuscript version 4
6 Feb 2022 Reviewed Reviewer Report - Evaldo Favi
8 Feb 2022 Reviewed Reviewer Report
6 Mar 2022 Author responded Author comments - RYOICHI MIYAZAKI
Resubmission - Version 5
6 Mar 2022 Submitted Manuscript version 5
22 Mar 2022 Reviewed Reviewer Report - Evaldo Favi
2 Apr 2022 Reviewed Reviewer Report
8 Apr 2022 Author responded Author comments - RYOICHI MIYAZAKI
Resubmission - Version 6
8 Apr 2022 Submitted Manuscript version 6
Publishing
18 Apr 2022 Editorially accepted
2 May 2022 Article published 10.1186/s12882-022-02793-9

You can find further information about peer review here.

Back to article page